Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
X www.clinicaltrials.gov. Once you are on the website, type “NCT03402841”
into the search box and click “Search”.
X http://www.clinicaltrialsregister.eu. Once you are on the website, click “Home and
Search”, then type “2017-002767-17” in the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D0816C00020”
into the search box, and click “Find a Study”.
Full Study Title: OPINION – A Phase IIIb, Single-arm, Open-label Multicentre Study of
Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed non-Germline BRCA
Mutated Ovarian Cancer Patients who are in Complete or Partial Response Following
Platinum-based Chemotherapy
AstraZeneca Protocol Number: D0816C00020
National Clinical Trials Number: NCT03402841
EudraCT Number: 2017-002767-17
AstraZeneca sponsored this study and has its headquarters at Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_09_24
12 | Clinical Study Results